US FDA drafts guidance on aspirin labelling

16 January 2017 - Deborah Wilkes

The US Food and Drug Administration (FDA) is encouraging companies that market OTC aspirin products with "cardiovascular-related imagery" to remind consumers to consult a healthcare professional.